Medpace Holdings (MEDP) Tops Q4 EPS by 8c, FY EPS Guidance Misses

Medpace Holdings (NASDAQ: MEDP) reported Q4 EPS of $0.75, $0.08 better than the analyst estimate of $0.67. Revenue for the quarter came in at $192.1 million versus the consensus estimate of $184.96 million.

GUIDANCE:

Medpace Holdings sees FY2019 EPS of $2.58-$2.69, versus the consensus of $2.92. Medpace Holdings sees FY2019 revenue of $783-807 million, versus the consensus of $799.2 million.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.

You May Also Be Interested In

• SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
• AI and memory not a classic bubble, but future returns uncertain - strategist
• Uxin Limited (UXIN) Reports Q3 EPS of $0.00